Glenmark launches SUTIB (Sunitinib) –priced 96% lower than the innovator brand
Oral capsules, highly affordable at Rs. 7000 (50 mg), Rs. 3600 (25 mg) and Rs. 1840 (12.5 mg) per month…
Oral capsules, highly affordable at Rs. 7000 (50 mg), Rs. 3600 (25 mg) and Rs. 1840 (12.5 mg) per month…
Glenmark Pharmaceuticals, a research-led, integrated global pharmaceutical company, today announced that it will introduce a 400 mg version of oral…